Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Photo

Differences in presentation of younger and older systemic sclerosis (SSc) patients in clinical trials


  • Please log in to reply
No replies to this topic

#1 Jeannie McClelland

Jeannie McClelland

    Senior Gold Member

  • ISN Support Specialists
  • PipPipPipPipPipPipPipPipPipPip
  • 1,706 posts
  • Location:in the Rocky Mountains of the USA

Posted 02 January 2011 - 10:31 AM

Differences in presentation of younger and older systemic sclerosis (SSc) patients in clinical trials. After adjustment for population norms and potential confounders, including medications, only differences in alkaline phosphatise and CK (muscle enzymes) remain between younger and older patients with SSc. Overall, older patients with SSc in clinical trials seem to be more similar to younger patients than was previously thought. Weng HH. (PubMed) Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 62):S10-4. (Also see: Clinical Trials)

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
Jeannie McClelland
(Retired) ISN Director of Support Services
(Retired) ISN Sclero Forums Manager
(Retired) ISN Blog Manager
(Retired) ISN Assistant News Guide
(Retired) ISN Artist
International Scleroderma Network